Glaxo Malarone Malaria Prophylaxis Will Subsidize Africa Donation Program
Glaxo is launching the anti-malarial agent Malarone at a price $1 per tablet higher in the U.S. than in the U.K.
You may also be interested in...
Pfizer's research and product donation programs for Zithromax in the developing world help to build the brand's image with infectious disease specialists, Global Pharmaceuticals President Karen Katen told analysts during Pfizer's recent business review.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011